miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease
Researchers at miRagen Therapeutics discovered microRNA-206 plays a crucial role in ALS progression and neuromuscular synaptic regeneration. This finding could lead to novel therapeutic interventions for neuromuscular disorders, offering hope for patients suffering from ALS and other diseases.